Hemogenyx Pharmaceuticals PLC (HEMO)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

755.00p

Buy

850.00p

arrow-up57.50p (+7.31%)

Prices updated at 24 Apr 2026, 16:30 BST

Prices minimum 15 mins delay

Prices in GBX

Hemogenyx Pharmaceuticals PLC is a preclinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies and treatments for blood diseases, like leukemia and lymphoma.

FTSE All-Share

-0.66%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	844.00p - 741.00p
	1,800.00p - 124.00p
	-
	50.54m
	-
	500
	23,176
	-
	57,602.69
	1.54
	3.50m
	GB00BQVXM815
	-2.31
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.